RESEARCH DEVELOPMENT HUMAN

Brand Owner (click to sort) Address Description
CASEBIA Casebia Therapeutics Limited Liability Partnership The Old Bakehouse, Course Road Ascot, Berkshire SL57HL United Kingdom Research and development of human therapeutics using gene editing; pharmaceutical research and development services;
PIPPIN AKERO THERAPEUTICS, INC. 170 Harbor Way, Third Floor South San Francisco CA 94080 Research and development of human therapeutics; pharmaceutical research and development services;
SCIOS SCIOS INC. 820 West Maude Avenue Sunnyvale CA 94085 research and development of human therapeutic and diagnostic products;
TREGA HOUGHTEN PHARMACEUTICALS, INC. 3550 General Atomics Court San Diego CA 92121 research and development of human pharmaceuticals, diagnostic agents, agricultural chemicals, and veterinary drugs for others;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A bacterial ?1,3-fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing ?1,3-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, and siayl Lewis X, which are structurally similar to certain tumor-associated carbohy-drate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors. In addition the polypeptide of the invention can be used to develop diagnostic and research assays to determine the presence of H. pylori in human specimens.